Debt-to-equity of PLIANT THERAPEUTICS, INC. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PLIANT THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • PLIANT THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 34%, a 80% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PLIANT THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 34% +15% +80% 30 Sep 2025
Q2 2025 32% +18% +130% 30 Jun 2025
Q1 2025 29% +18% +175% 31 Mar 2025
Q4 2024 25% +17% +235% 31 Dec 2024
Q3 2024 19% +11% +138% 30 Sep 2024
Q2 2024 14% +5% +56% 30 Jun 2024
Q1 2024 10% -1% -6.1% 31 Mar 2024
Q4 2023 7% -7% -48% 31 Dec 2023
Q3 2023 8% -6% -44% 30 Sep 2023
Q2 2023 9% -4% -31% 30 Jun 2023
Q1 2023 11% +3% +31% 31 Mar 2023
Q4 2022 14% +8% +124% 31 Dec 2022
Q3 2022 14% +9% +195% 30 Sep 2022
Q2 2022 13% +9% +199% 30 Jun 2022
Q1 2022 8% +4% +103% 31 Mar 2022
Q4 2021 6% 31 Dec 2021
Q3 2021 5% 30 Sep 2021
Q2 2021 4% 30 Jun 2021
Q1 2021 4% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.